| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
|
Wigertz, Annette
|
|
2012
|
133 |
1 |
p. 367-373
|
artikel
|
| 2 |
A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response
|
Krijgsman, Oscar
|
|
2011
|
133 |
1 |
p. 37-47
|
artikel
|
| 3 |
Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
|
Ito, Tokiko
|
|
2011
|
133 |
1 |
p. 145-159
|
artikel
|
| 4 |
Anti-tumor effects of a novel retinoic acid metabolism blocking agent VN/14-1 in the N-methyl-N-nitrosourea-induced rat mammary carcinoma model and its effects on the uterus
|
Goss, Paul E.
|
|
2011
|
133 |
1 |
p. 137-144
|
artikel
|
| 5 |
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO
|
Biswas, Swati
|
|
2012
|
133 |
1 |
p. 347-355
|
artikel
|
| 6 |
Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US
|
Lipscomb, Joseph
|
|
2012
|
133 |
1 |
p. 285-296
|
artikel
|
| 7 |
Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin
|
Ruiz de Garibay, Gorka
|
|
2012
|
133 |
1 |
p. 273-283
|
artikel
|
| 8 |
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients
|
Nes, Johanna G. H. van
|
|
2011
|
133 |
1 |
p. 49-59
|
artikel
|
| 9 |
Disparities in breast cancer care delivery: solving a complex puzzle
|
Friese, Christopher R.
|
|
2012
|
133 |
1 |
p. 297-299
|
artikel
|
| 10 |
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study
|
Kuter, Irene
|
|
2012
|
133 |
1 |
p. 237-246
|
artikel
|
| 11 |
Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
|
Zeng, Xianke
|
|
2011
|
133 |
1 |
p. 117-126
|
artikel
|
| 12 |
Erratum to: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
|
McAllister, Sean D.
|
|
2012
|
133 |
1 |
p. 401-404
|
artikel
|
| 13 |
Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
|
Pohorelic, Brant
|
|
2011
|
133 |
1 |
p. 215-216
|
artikel
|
| 14 |
Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing
|
Leeneer, K. De
|
|
2012
|
133 |
1 |
p. 393-398
|
artikel
|
| 15 |
Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients
|
Peurala, Emmi
|
|
2011
|
133 |
1 |
p. 179-188
|
artikel
|
| 16 |
Favorable outcome associated with an IGF-1 ligand signature in breast cancer
|
Mu, Lina
|
|
2012
|
133 |
1 |
p. 321-331
|
artikel
|
| 17 |
Genetic heterogeneity in HER2 testing may influence therapy eligibility
|
Bernasconi, Barbara
|
|
2011
|
133 |
1 |
p. 161-168
|
artikel
|
| 18 |
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04)
|
Takei, Hiroyuki
|
|
2012
|
133 |
1 |
p. 227-236
|
artikel
|
| 19 |
Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers
|
Park, Seho
|
|
2012
|
133 |
1 |
p. 311-320
|
artikel
|
| 20 |
Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
|
Degnim, Amy C.
|
|
2011
|
133 |
1 |
p. 169-177
|
artikel
|
| 21 |
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice
|
Weycker, Derek
|
|
2012
|
133 |
1 |
p. 301-310
|
artikel
|
| 22 |
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
|
Croker, Alysha K.
|
|
2011
|
133 |
1 |
p. 75-87
|
artikel
|
| 23 |
Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
|
Ait-Tihyaty, Maria
|
|
2011
|
133 |
1 |
p. 217-226
|
artikel
|
| 24 |
Not so fast: the use of incomplete data to devalue the role of mammography screening
|
Kopans, Daniel B.
|
|
2012
|
133 |
1 |
p. 399
|
artikel
|
| 25 |
Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy
|
Panis, C.
|
|
2011
|
133 |
1 |
p. 89-97
|
artikel
|
| 26 |
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1
|
Zeng, Hongmei
|
|
2011
|
133 |
1 |
p. 127-135
|
artikel
|
| 27 |
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)
|
Azim, Hatem A.
|
|
2012
|
133 |
1 |
p. 387-391
|
artikel
|
| 28 |
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer
|
Maae, Else
|
|
2012
|
133 |
1 |
p. 257-265
|
artikel
|
| 29 |
Prospective study of breast tomosynthesis as a triage to assessment in screening
|
Bernardi, Daniela
|
|
2012
|
133 |
1 |
p. 267-271
|
artikel
|
| 30 |
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer
|
He, Min
|
|
2011
|
133 |
1 |
p. 111-116
|
artikel
|
| 31 |
Risk prediction models of breast cancer: a systematic review of model performances
|
Anothaisintawee, Thunyarat
|
|
2011
|
133 |
1 |
p. 1-10
|
artikel
|
| 32 |
Role of interleukin-10 in breast cancer
|
Hamidullah,
|
|
2011
|
133 |
1 |
p. 11-21
|
artikel
|
| 33 |
Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment
|
Pohorelic, Brant
|
|
2011
|
133 |
1 |
p. 201-214
|
artikel
|
| 34 |
Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
|
Yang, Dong
|
|
2011
|
133 |
1 |
p. 189-199
|
artikel
|
| 35 |
Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy?
|
Park, Yeon Hee
|
|
2012
|
133 |
1 |
p. 247-255
|
artikel
|
| 36 |
Social networks, social support and burden in relationships, and mortality after breast cancer diagnosis
|
Kroenke, Candyce H.
|
|
2012
|
133 |
1 |
p. 375-385
|
artikel
|
| 37 |
Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients
|
Wheeler, Stephanie B.
|
|
2012
|
133 |
1 |
p. 333-345
|
artikel
|
| 38 |
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
|
Moura, Vera
|
|
2011
|
133 |
1 |
p. 61-73
|
artikel
|
| 39 |
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents
|
Lu, Wenjie Jessie
|
|
2011
|
133 |
1 |
p. 99-109
|
artikel
|
| 40 |
Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic comparison of elasticity and BIRADS scoring
|
Sadigh, Gelareh
|
|
2011
|
133 |
1 |
p. 23-35
|
artikel
|
| 41 |
Willingness to use tamoxifen to prevent breast cancer among diverse women
|
Kaplan, Celia Patricia
|
|
2012
|
133 |
1 |
p. 357-366
|
artikel
|
Tijdschrift beschrijving